Eukarÿs

Eukarÿs SAS is a biotechnology startup based in France, founded in 2010. The company has developed a groundbreaking artificial expression system, C3P3, capable of autonomously synthesizing messenger RNA (mRNA) and the desired protein in mammalian and other eukaryotic cells. This innovative technology has the potential to radically reduce production costs for a range of protein-based drugs, including vaccines, viral vectors for gene therapy, and monoclonal antibodies.

With their slogan "mRNA is in our DNA!", Eukarÿs aims to revolutionize the production processes of innovative medicines by offering Pharma/Biotech, CDMO, and academic institutions a suite of tools based on the C3P3 system for both research and industrial production. By enabling high-yield production in mammalian cells, the company is poised to make a significant impact in the biopharmaceutical industry.

Despite being founded in 2010, specific information about recent investments and investors is currently unavailable. Nonetheless, Eukarÿs SAS presents a compelling proposition in the biotechnology sector with their pioneering technology and potential to disrupt the traditional production methods of pharmaceuticals.